{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:09:04Z","timestamp":1746158944602},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ejpn.2014.02.006","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T11:01:22Z","timestamp":1394794882000},"page":"526-528","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Infantile anti-MuSK positive myasthenia gravis in a patient with autoimmune polyendocrinopathy type 3"],"prefix":"10.1016","volume":"18","author":[{"given":"Ozgur","family":"Duman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Resit","family":"Koken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Taner","family":"Baran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senay","family":"Haspolat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haluk","family":"Topaloglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2014.02.006_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis-Pathogenesis at the neuromuscular junction","volume":"43","author":"Gomez","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejpn.2014.02.006_bib2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1468-1331.2009.02624.x","article-title":"Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece","volume":"16","author":"Tsiamalos","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ejpn.2014.02.006_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mus.21533","article-title":"Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience","volume":"41","author":"Pasnoor","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejpn.2014.02.006_bib4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0929-6646(08)60171-0","article-title":"Clinical characteristics of MuSK antibody-positive myasthenia gravis in Taiwan","volume":"107","author":"Huang","year":"2008","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.ejpn.2014.02.006_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2014.02.006_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.pediatrneurol.2008.11.014","article-title":"Long remission in muscle-specific kinase antibody-positive juvenile myasthenia","volume":"40","author":"Anlar","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2014.02.006_bib7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1399-5448.2009.00622.x","article-title":"Autoimmune polyglandular syndrome type 3 and growth hormone deficiency","volume":"11","author":"Quintos","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.ejpn.2014.02.006_bib8","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/01.WNL.0000041625.41937.FF","article-title":"AChR phosphorylation and indirect inhibition of AChR function in seronegative MG","volume":"59","author":"Plested","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2014.02.006_bib9","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2014.02.006_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/edrv.23.3.0466","article-title":"Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes:autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction","volume":"23","author":"Betterle","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejpn.2014.02.006_bib11","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2230.2006.02171.x","article-title":"Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B + C and 4","volume":"31","author":"Amerio","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ejpn.2014.02.006_bib12","series-title":"Pediatric endocrinology","first-page":"671","article-title":"Autoimmune polyglanduler syndromes","author":"Schatz","year":"2002"},{"key":"10.1016\/j.ejpn.2014.02.006_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814000403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814000403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T03:52:09Z","timestamp":1538797929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379814000403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1090379814000403"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.02.006","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infantile anti-MuSK positive myasthenia gravis in a patient with autoimmune polyendocrinopathy type 3","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}